ReproNeuro Human iPS Cell-derived Neurons

Catalog RCDN001N
Size 3x106 cells (one 96-well plate)
Price
$700.00
$700.00
Availability In stock
Catalog
RCDN001N

Product Overview

ReproNeuro (RCDN001)

Wild-type human brain cell neurons for general purpose assays

Frozen human iPSC-derived neurons for 96-well high throughput & high content assays

  • Frozen as a suspension of individualized neuroprogenitor cells
  • Rapidly differentiate into neurons during in vitro growth and maturation
  • Functional for in vitro neurotoxicity assays and drug discovery
  • Form dendritic connections leading to synchronized burst behavior around week 6 in vitro
  • Responsive to various reference compounds that modulate neuron electrophysiology
  • Expresses multiple neuron-specific markers, indicating a mixed population of neuron types
  • Two different culture media are available separately

ReproNeuro iPS-derived neurons are delivered as a suspension of frozen single cells that retain structural and functional integrity, and high viability thanks to REPROCELL's proprietary cryopreservation technology. Thawed and plated ReproNeuro cells mature during 2-3 weeks of culture on surfaces treated with ReproNeuro Coat (RCDN201).

Types of ReproNeuro Media

Note that one of the following media is required for proper maturation of the ReproNeuro cells:

  • ReproNeuro Culture Medium (RCDN101); standard medium for general purpose assays
  • ReproNeuro MQ Culture Medium (RCDN102); a specialty medium formulated with rat astrocyte supplementation resulting in maximum performance in MEA (multiple electrode array) assays

Types of ReproNeuro Cells

Two different versions of ReproNeuro cells are currently available.  Both are nearly functionally equivalent but differ in how they were derived.  If you have a preference, please specify one in your order.

  • Lot "A" is from an iPS cell derived by retrovirus technology and from genetic background A.  This lot is the isogenic control for ReproNeuro AD-Mutation cells (RCDN002N).
  • Lot "B" is from an iPS cell derived by RNA-reprogramming technology and is from genetic background B (32 yr old healthy male)


Product Specifications

Product Name
ReproNeuro Human iPS Cell-derived Neurons
Catalog Number
RCDN001N
Size
3x106 cells (one 96-well plate)
Storage and Stability
Store in liquid nitrogen

Intracellular Ca2+ signaling imagine

The dynamic modulation of Ca2+concentration in ReproNeuro™ differentiated neuronal cells can be observed with the application of a fluorescent calcium binding dye (Fluo-8). Glutamine-induced calcium flux can be observed in nearly all of the visible neurons.

Before inductionBefore induction

After 100 μM Glutamine inductionAfter 100 μM Glutamine induction

Dopamine release by dopaminergic neurons derived from ReproNeuro cells

ReproNeuro™ cells derived from human iPS cells were first treated with high concentration Ca2+ (56 μM) to polarize the cells. After polarization, increased dopamine concentration in the culture medium was detected, indicating the functional capability of dopamine release in ReproNeuro™ cells.

Dopamine uptake by dopaminergic neurons derived from ReproNeuro cells

ReproNeuro™ cells derived from human iPS cells were treated with DMSO or DAT (Dopamine Transporter) inhibitor (GBR12909, 20 μM). Dopamine uptake was measured by Neurotransmitter transporter uptake assay kit (Molecular Devices). The fluorescence intensity of controls decreased after addition of DAT inhibitor, indicating a block of neurotransmitter transporter in ReproNeuro™.

Data Sheet

Safety Data Sheets


Publications

  • Odawara, Aoi, Masao Gotoh, and Ikuro Suzuki. “A three-dimensional neuronal culture technique that controls the direction of neurite elongation and the position of soma to mimic the layered structure of the brain.” RSC Adv. (2013).
  • Bottiglieri, Teodoro, et al. “Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.” The Journal of Neuroscience 32.27 (2012): 9173-9181.

Presentations

  • Society for Biomolecular Sciences(SBS), 14th AnnualConference & Exhibition 2008 (St. Louis), poster session, April 2008.
  • IBC Asia’s 4th Annual Stem Cells Asia Congress (Singapore), oral session, June 2008.
  • ELRIG and SBS Present: Drug Discovery (UK) poster session, September 2008.
  • Advances in Stem Cell Discoveries (San Francisco) oral session, September 2008.
  • Stem Cells: Drug Discovery and Therapeutics (London) oral session, February 2008.
  • Society for Biomolecular Science 15th Annual Conference (France), poster session, Best Poster 2009 Award-winning, April 2009.
  • Stem Cells and Regenerative Medicine Europe (UK), September 2009, Best Poster 2009 Award-winning.
  • MipTec Conference 2009, October 13-15, Basel Invited Lecture.
  • The 74th Annual Scientific Meeting of the Japanese Circulation Society(Kyoto), March 2010.
  • The 130th The Pharmaceutical Society of Japan(Okayama), March 2010.
  • The Society of Toxicology (SOT) 51st Annual Meeting (CA, USA), poster session, March 2012.
  • Safety Pharmacology Society (SPS), 13th annual meeting 2013 (Rotterdam, Netherlands), poster session, September 2013.
  • Automated Patch-Clamp systems and Ion Channel Expressing Cells 2013 (Tokyo), Verbal presentation 2013 Nov.
  • The 7th Takeda Science Foundation Symposium (Osaka), Poster presentation 2014 Jan.

Product Specifications

Product Name
ReproNeuro Human iPS Cell-derived Neurons
Catalog Number
RCDN001N
Size
3x106 cells (one 96-well plate)
Storage and Stability
Store in liquid nitrogen

Intracellular Ca2+ signaling imagine

The dynamic modulation of Ca2+concentration in ReproNeuro™ differentiated neuronal cells can be observed with the application of a fluorescent calcium binding dye (Fluo-8). Glutamine-induced calcium flux can be observed in nearly all of the visible neurons.

Before inductionBefore induction

After 100 μM Glutamine inductionAfter 100 μM Glutamine induction

Dopamine release by dopaminergic neurons derived from ReproNeuro cells

ReproNeuro™ cells derived from human iPS cells were first treated with high concentration Ca2+ (56 μM) to polarize the cells. After polarization, increased dopamine concentration in the culture medium was detected, indicating the functional capability of dopamine release in ReproNeuro™ cells.

Dopamine uptake by dopaminergic neurons derived from ReproNeuro cells

ReproNeuro™ cells derived from human iPS cells were treated with DMSO or DAT (Dopamine Transporter) inhibitor (GBR12909, 20 μM). Dopamine uptake was measured by Neurotransmitter transporter uptake assay kit (Molecular Devices). The fluorescence intensity of controls decreased after addition of DAT inhibitor, indicating a block of neurotransmitter transporter in ReproNeuro™.

Data Sheet

Safety Data Sheets

Publications

  • Odawara, Aoi, Masao Gotoh, and Ikuro Suzuki. “A three-dimensional neuronal culture technique that controls the direction of neurite elongation and the position of soma to mimic the layered structure of the brain.” RSC Adv. (2013).
  • Bottiglieri, Teodoro, et al. “Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.” The Journal of Neuroscience 32.27 (2012): 9173-9181.

Presentations

  • Society for Biomolecular Sciences(SBS), 14th AnnualConference & Exhibition 2008 (St. Louis), poster session, April 2008.
  • IBC Asia’s 4th Annual Stem Cells Asia Congress (Singapore), oral session, June 2008.
  • ELRIG and SBS Present: Drug Discovery (UK) poster session, September 2008.
  • Advances in Stem Cell Discoveries (San Francisco) oral session, September 2008.
  • Stem Cells: Drug Discovery and Therapeutics (London) oral session, February 2008.
  • Society for Biomolecular Science 15th Annual Conference (France), poster session, Best Poster 2009 Award-winning, April 2009.
  • Stem Cells and Regenerative Medicine Europe (UK), September 2009, Best Poster 2009 Award-winning.
  • MipTec Conference 2009, October 13-15, Basel Invited Lecture.
  • The 74th Annual Scientific Meeting of the Japanese Circulation Society(Kyoto), March 2010.
  • The 130th The Pharmaceutical Society of Japan(Okayama), March 2010.
  • The Society of Toxicology (SOT) 51st Annual Meeting (CA, USA), poster session, March 2012.
  • Safety Pharmacology Society (SPS), 13th annual meeting 2013 (Rotterdam, Netherlands), poster session, September 2013.
  • Automated Patch-Clamp systems and Ion Channel Expressing Cells 2013 (Tokyo), Verbal presentation 2013 Nov.
  • The 7th Takeda Science Foundation Symposium (Osaka), Poster presentation 2014 Jan.